Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


03.12.2018

1 Am J Obstet Gynecol
1 Am Soc Clin Oncol Educ Book
1 Arch Gynecol Obstet
3 Asian Pac J Cancer Prev
1 Biochem Biophys Res Commun
1 Biofactors
1 Biomed Pharmacother
2 BMC Cancer
2 BMC Health Serv Res
1 BMC Womens Health
1 Brachytherapy
1 Braz J Med Biol Res
1 Clin Transl Oncol
2 Diagn Cytopathol
1 Diagn Pathol
1 Eur J Radiol
1 Exp Mol Pathol
6 Gynecol Oncol
1 Health Policy
1 Infect Agent Cancer
1 Int J Cancer
1 Int J Equity Health
1 Int J Gynecol Pathol
2 J Cancer Res Ther
1 J Cell Biochem
1 J Cell Physiol
2 J Contemp Brachytherapy
1 J Gen Intern Med
2 J Gynecol Oncol
1 J Low Genit Tract Dis
1 J Med Virol
1 J Transl Med
1 J Vasc Interv Radiol
1 Minerva Ginecol
2 Oncol Rep
1 Sci Rep
1 Sociol Health Illn
1 Viruses


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Obstet Gynecol

  1. MILLER K, Dilley SE, Huh WK
    Lessons learned from domestic and international human papillomavirus vaccination programs: a review.
    Am J Obstet Gynecol. 2018;218:467-473.
    PubMed     Text format     Abstract available


    Am Soc Clin Oncol Educ Book

  2. ESKANDER RN
    The Epigenetic Landscape in the Treatment of Gynecologic Malignancies.
    Am Soc Clin Oncol Educ Book. 2018;:480-487.
    PubMed     Text format     Abstract available


    Arch Gynecol Obstet

  3. MALMSTEN C, Hellberg P, Bergmark K, Dahm-Kahler P, et al
    Long-term fertility, oncological, and quality-of-life outcomes after trachelectomy in early stage cervical cancer.
    Arch Gynecol Obstet. 2018 Nov 28. pii: 10.1007/s00404-018-4972.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  4. JAYA BK, Kumar SS
    Image Registration based Cervical Cancer Detection and Segmentation Using ANFIS Classifier
    Asian Pac J Cancer Prev. 2018;19:3203-3209.
    PubMed     Text format     Abstract available

  5. HOSSEINI MS, Khosravi D, Farzaneh F, Ebrahimi A, et al
    Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia
    Asian Pac J Cancer Prev. 2018;19:3071-3075.
    PubMed     Text format     Abstract available

  6. DAHBI Z, Sbai A, Mezouar L
    Sexuality of Moroccan Survivors of Cervical Cancer: A Prospective Data
    Asian Pac J Cancer Prev. 2018;19:3077-3079.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  7. ZHANG Y, Li P, Hu J, Zhao LN, et al
    Role and mechanism of miR-4778-3p and its targets NR2C2 and Med19 in cervical cancer radioresistance.
    Biochem Biophys Res Commun. 2018 Nov 22. pii: S0006-291X(18)32536.
    PubMed     Text format     Abstract available


    Biofactors

  8. MAHMOODI P, Fani M, Rezayi M, Avan A, et al
    Early detection of cervical cancer based on high-risk HPV DNA-based genosensors: A systematic review.
    Biofactors. 2018 Nov 29. doi: 10.1002/biof.1465.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  9. SEERVI M, Rani A, Sharma AK, Santhosh Kumar TR, et al
    ROS mediated ER stress induces Bax-Bak dependent and independent apoptosis in response to Thioridazine.
    Biomed Pharmacother. 2018;106:200-209.
    PubMed     Text format     Abstract available


    BMC Cancer

  10. WANG H, Cheng X, Ye J, Xu X, et al
    Distribution of human papilloma virus genotype prevalence in invasive cervical carcinomas and precancerous lesions in the Yangtze River Delta area, China.
    BMC Cancer. 2018;18:487.
    PubMed     Text format     Abstract available

  11. HUSAIYIN S, Han L, Wang L, Ma C, et al
    Factors associated with high-risk HPV infection and cervical cancer screening methods among rural Uyghur women aged > 30 years in Xinjiang.
    BMC Cancer. 2018;18:1162.
    PubMed     Text format     Abstract available


    BMC Health Serv Res

  12. MUSA J, Achenbach CJ, Evans CT, Jordan N, et al
    Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria.
    BMC Health Serv Res. 2018;18:885.
    PubMed     Text format     Abstract available

  13. SHEN J, Olwanda E, Kahn JG, Huchko MJ, et al
    Cost of HPV screening at community health campaigns (CHCs) and health clinics in rural Kenya.
    BMC Health Serv Res. 2018;18:378.
    PubMed     Text format     Abstract available


    BMC Womens Health

  14. DARQUY S, Moutel G, Jullian O, Barre S, et al
    Towards equity in organised cancer screening: the case of cervical cancer screening in France.
    BMC Womens Health. 2018;18:192.
    PubMed     Text format     Abstract available


    Brachytherapy

  15. SMALL C, Harmon G, Weaver J, Vivirito V, et al
    Impact on treatment time of MRI-based brachytherapy in two implants (4 doses) compared with CT-based brachytherapy in five implants for cervical cancer.
    Brachytherapy. 2018 Nov 26. pii: S1538-4721(18)30594.
    PubMed     Text format     Abstract available


    Braz J Med Biol Res

  16. XU S, Fan Y, Li D, Liu Y, et al
    Glycoprotein nonmetastatic melanoma protein B accelerates tumorigenesis of cervical cancer in vitro by regulating the Wnt/beta-catenin pathway.
    Braz J Med Biol Res. 2018;52:e7567.
    PubMed     Text format     Abstract available


    Clin Transl Oncol

  17. HOLUB K, Biete A
    Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients.
    Clin Transl Oncol. 2018 Nov 23. pii: 10.1007/s12094-018-1991.
    PubMed     Text format     Abstract available


    Diagn Cytopathol

  18. NISHIUMI Y, Nishimura T, Kashu I, Aoki T, et al
    Adenocarcinoma in situ admixed with small cell neuroendocrine carcinoma of the cervix: A case report with cytological features.
    Diagn Cytopathol. 2018;46:752-755.
    PubMed     Text format     Abstract available

  19. BARODAWALA SM, Chadha K, Kavishwar V, Murthy A, et al
    Cervical cancer screening by molecular Pap-transformation of gynecologic cytology.
    Diagn Cytopathol. 2018 Nov 23. doi: 10.1002/dc.24116.
    PubMed     Text format     Abstract available


    Diagn Pathol

  20. LIANG Y, Lu W, Zhang X, Lu B, et al
    Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer.
    Diagn Pathol. 2018;13:93.
    PubMed     Text format     Abstract available


    Eur J Radiol

  21. LI K, Sun H, Lu Z, Xin J, et al
    Value of [(18)F]FDG PET radiomic features and VEGF expression in predicting pelvic lymphatic metastasis and their potential relationship in early-stage cervical squamous cell carcinoma.
    Eur J Radiol. 2018;106:160-166.
    PubMed     Text format     Abstract available


    Exp Mol Pathol

  22. AALIJAHAN H, Ghorbian S
    Long non-coding RNAs and cervical cancer.
    Exp Mol Pathol. 2018;106:7-16.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  23. ZHU B, Pan Y, Zheng X, Zhang Q, et al
    A clinical, biologic and mechanistic analysis of the role of ZNF692 in cervical cancer.
    Gynecol Oncol. 2018 Nov 19. pii: S0090-8258(18)31423.
    PubMed     Text format     Abstract available

  24. SIMONDS HM, Botha MH, Neugut AI, Van Der Merwe FH, et al
    Five-year overall survival following chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in a South African cohort.
    Gynecol Oncol. 2018 Sep 4. pii: S0090-8258(18)31168.
    PubMed     Text format     Abstract available

  25. ZHANG L, Xu XQ, Hu SY, Chen F, et al
    Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China.
    Gynecol Oncol. 2018 Sep 27. pii: S0090-8258(18)31231.
    PubMed     Text format     Abstract available

  26. SPAANS VM, Scheunhage DA, Barzaghi B, de Kroon CD, et al
    Independent validation of the prognostic significance of invasion patterns in endocervical adenocarcinoma: Pattern A predicts excellent survival.
    Gynecol Oncol. 2018;151:196-201.
    PubMed     Text format     Abstract available

  27. GHELARDI A, Parazzini F, Martella F, Pieralli A, et al
    SPERANZA project: HPV vaccination after treatment for CIN2.
    Gynecol Oncol. 2018 Sep 6. pii: S0090-8258(18)31163.
    PubMed     Text format    

  28. BOARDMAN CH, Brady WE, Dizon DS, Kunos CA, et al
    A Phase I Evaluation of Extended Field Radiation Therapy With Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women With Cervical Carcinoma Metastatic to the Para-aortic Lymph Nodes: An NRG Oncology/Gynecologi
    Gynecol Oncol. 2018 Aug 31. pii: S0090-8258(18)31095.
    PubMed     Text format     Abstract available


    Health Policy

  29. WILLEMS B, Bracke P
    Participants, Physicians or Programmes: Participants' educational level and initiative in cancer screening.
    Health Policy. 2018;122:422-430.
    PubMed     Text format     Abstract available


    Infect Agent Cancer

  30. MA M, Feng Y, Fan P, Yao X, et al
    Human papilloma virus E1-specific T cell immune response is associated with the prognosis of cervical cancer patients with squamous cell carcinoma.
    Infect Agent Cancer. 2018;13:35.
    PubMed     Text format     Abstract available


    Int J Cancer

  31. UTADA M, Chernyavskiy P, Lee WJ, Franceschi S, et al
    Increasing risk of uterine cervical cancer among young Japanese women: Comparison of incidence trends in Japan, South Korea and Japanese-Americans between 1985 and 2012.
    Int J Cancer. 2018 Nov 25. doi: 10.1002/ijc.32014.
    PubMed     Text format     Abstract available


    Int J Equity Health

  32. IDEHEN EE, Koponen P, Harkanen T, Kangasniemi M, et al
    Disparities in cervical screening participation: a comparison of Russian, Somali and Kurdish immigrants with the general Finnish population.
    Int J Equity Health. 2018;17:56.
    PubMed     Text format     Abstract available


    Int J Gynecol Pathol

  33. STRICKLAND SV, Rendi MH, Garcia RL, Norquist BS, et al
    Evaluation of Intraoperative Assessments in the Management of Endometrial Carcinoma: A Retrospective Quality Assurance Review.
    Int J Gynecol Pathol. 2018;37:414-420.
    PubMed     Text format     Abstract available


    J Cancer Res Ther

  34. ALIFU M, Hu YH, Dong T, Wang RZ, et al
    HLA-A*30:01 and HLA-A*33:03 are the protective alleles while HLA-A*01:01 serves as the susceptible gene for cervical cancer patients in Xinjiang, China.
    J Cancer Res Ther. 2018;14:1266-1272.
    PubMed     Text format     Abstract available

  35. METCALFE E, Arik D, Oge T, Etiz D, et al
    CD105 (endoglin) expression as a prognostic marker of angiogenesis in squamous cell cervical cancer treated with radical radiotherapy.
    J Cancer Res Ther. 2018;14:1373-1378.
    PubMed     Text format     Abstract available


    J Cell Biochem

  36. LI J, Liu R, Tang S, Feng F, et al
    The effect of long noncoding RNAs HOX transcript antisense intergenic RNA single-nucleotide polymorphisms on breast cancer, cervical cancer, and ovarian cancer susceptibility: A meta-analysis.
    J Cell Biochem. 2018 Nov 28. doi: 10.1002/jcb.27975.
    PubMed     Text format     Abstract available


    J Cell Physiol

  37. LI YJ, Wang Y, Wang YY
    MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    J Cell Physiol. 2018 Nov 27. doi: 10.1002/jcp.27645.
    PubMed     Text format     Abstract available


    J Contemp Brachytherapy

  38. TUNTIPUMIAMORN L, Lohasammakul S, Dankulchai P, Nakkrasae P, et al
    Comparison of impact of target delineation of computed tomography- and magnetic resonance imaging-guided brachytherapy on dose distribution in cervical cancer.
    J Contemp Brachytherapy. 2018;10:418-424.
    PubMed     Text format     Abstract available

  39. KOPER K, Dziobek K, Makarewicz R, Terlikiewicz J, et al
    The analysis of the long-term outcomes in elderly women treated for locally advanced cervical cancer.
    J Contemp Brachytherapy. 2018;10:411-417.
    PubMed     Text format     Abstract available


    J Gen Intern Med

  40. WEI M, Zhou W, Bi Y, Wang H, et al
    Rising Mortality Rate of Cervical Cancer in Younger Women in Urban China.
    J Gen Intern Med. 2018 Nov 27. pii: 10.1007/s11606-018-4732.
    PubMed     Text format     Abstract available


    J Gynecol Oncol

  41. VAN DER VELDEN J, Mom CH
    Tailoring radicality in early cervical cancer: how far can we go?
    J Gynecol Oncol. 2018 Nov 22. pii: 30.e30. doi: 10.3802/jgo.2019.
    PubMed     Text format     Abstract available

  42. QU A, Jiang P, Sun H, Jiang W, et al
    Efficacy and dosimetry analysis of image-guided radioactive 125I seed implantation as salvage treatment for pelvic recurrent cervical cancer after external beam radiotherapy.
    J Gynecol Oncol. 2018 Oct 30. pii: 30.e9. doi: 10.3802/jgo.2019.
    PubMed     Text format     Abstract available


    J Low Genit Tract Dis

  43. JACKSON R, Wang L, Jembere N, Murphy J, et al
    Why Do Women Get Cervical Cancer in an Organized Screening Program in Canada?
    J Low Genit Tract Dis. 2018 Nov 27. doi: 10.1097/LGT.0000000000000450.
    PubMed     Text format     Abstract available


    J Med Virol

  44. LIU H, Wei X, Xie Z, Wang X, et al
    Cervical human papillomavirus among 19,753 women attending gynecological department of a major comprehensive hospital in north Anhui China 2013-2016: implication for cervical cancer screening and prevention.
    J Med Virol. 2018 Nov 26. doi: 10.1002/jmv.25365.
    PubMed     Text format     Abstract available


    J Transl Med

  45. DABI Y, Simon V, Carcopino X, Bendifallah S, et al
    Therapeutic value of surgical paraaortic staging in locally advanced cervical cancer: a multicenter cohort analysis from the FRANCOGYN study group.
    J Transl Med. 2018;16:326.
    PubMed     Text format     Abstract available


    J Vasc Interv Radiol

  46. LEE H, Kim SJ, Hur S, Kim HS, et al
    The Feasibility of Mesenteric Intranodal Lymphangiography: Its Clinical Application for Refractory Postoperative Chylous Ascites.
    J Vasc Interv Radiol. 2018;29:1290-1292.
    PubMed     Text format    


    Minerva Ginecol

  47. DE FRANCISCIS P, La Manna V, Schiattarella A, Ambrosio D, et al
    [Diagnostic accuracy of endocervicoscopy as preoperative tool to improve the excisional treatment of cervical preneoplastic lesions].
    Minerva Ginecol. 2018;70:364-370.
    PubMed     Text format     Abstract available


    Oncol Rep

  48. WANG Z, Yu C, Wang H
    HOXA5 inhibits the proliferation and induces the apoptosis of cervical cancer cells via regulation of protein kinase B and p27.
    Oncol Rep. 2018 Nov 20. doi: 10.3892/or.2018.6874.
    PubMed     Text format     Abstract available

  49. VAZQUEZ-MELLADO MJ, Cortes-Ballinas LG, Blanco-Flores IC, Aguilar C, et al
    Erythropoietin promotes expression of survivin via STAT3 activation and reduces sensitivity to cisplatin in cervical cancer cells.
    Oncol Rep. 2018 Nov 27. doi: 10.3892/or.2018.6890.
    PubMed     Text format     Abstract available


    Sci Rep

  50. NATH B, Raza A, Sethi V, Dalal A, et al
    Understanding flow dynamics, viability and metastatic potency of cervical cancer (HeLa) cells through constricted microchannel.
    Sci Rep. 2018;8:17357.
    PubMed     Text format     Abstract available


    Sociol Health Illn

  51. PAUL KT, Wallenburg I, Bal R
    Putting public health infrastructures to the test: introducing HPV vaccination in Austria and the Netherlands.
    Sociol Health Illn. 2018;40:67-81.
    PubMed     Text format     Abstract available


    Viruses

  52. MCBRIDE AA, Munger K
    Expert Views on HPV Infection.
    Viruses. 2018;10.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: